Healthcare
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
BUFFALO, NY, July 20, 2026 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in advanced molecular imaging technology and comprehensive PET imaging solutions, today announced three new orders for its 64-slice PET-CT systems, each accompanied by multi-year service agreements, from leading nuclear cardiologists whose practices specialize in advanced cardiovascular diagnostics and interventional cardiac care. These new orders further expand Positron's comm
About this update from Positron Corp.
BUFFALO, NY, July 20, 2026 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in advanced molecular imaging technology and comprehensive PET imaging solutions, today announced three new orders for its 64-slice PET-CT systems, each accompanied by multi-year service agreements, from leading nuclear cardiologists whose practices specialize in advanced cardiovascular diagnostics and interventional cardiac care. These new orders further expand Positron's commercial momentum by adding new system sales and long-term support service agreements, supporting the anticipated market acceptance of the Company's advanced PET-CT technology, comprehensive support platform, and compelling value proposition. As the adoption of cardiac PET continues to accelerate and healthcare providers transition from traditional SPECT imaging, Positron believes it is well positioned to capitalize on this expanding market through its differentiated technology, recurring service model, and commitment to delivering superior clinical and economic value. "We believe Positron is entering a new chapter that can transform the molecular imaging industry," said Adel Abdullah, President and Chairman of Positron Corporation. "As we prepare to launch our advanced PET-CT platform, we are encouraged by the strong interest from hospitals and private practices across the United States, as well as emerging international markets. We believe our combination of advanced technology, comprehensive support services, and compelling economics has the potential to accelerate the adoption of the PET modality and/or transition from SPECT cardiac PET imaging. Upon commercial launch, we expect to attract a substantial number of new cardiac imaging customers, significantly expanding our installed base and strengthening our position in this rapidly growing market." Positron's advanced PET-CT systems are designed to deliver exceptional image quality, workflow efficiency, and economic value across both cardiac and oncology imaging. Featuring high-sensitivity detector technology, a patient-friendly 72 cm wide-bore gantry, and the smallest, lightest footprint in its class, the systems provide high-performance imaging while supporting lower radiation exposure and seamless integration into virtually any clinical environment. Backed by more than 30 years of experience and tens of thousa...